A Clinical Trial of TQA3038 Injection in Healthy Adult Subjects

Clinical trial NCT06085053 · UNKNOWN

Trial details

NCT number: NCT06085053
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepatitis b

Start date: 2023-11-30
Primary completion: 2024-12-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.